109 related articles for article (PubMed ID: 9524240)
1. Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome p450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital.
Watanabe I; Serizawa N
Gene; 1998 Mar; 210(1):109-16. PubMed ID: 9524240
[TBL] [Abstract][Full Text] [Related]
2. Cloning, characterization and expression of the gene encoding cytochrome P-450sca-2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor.
Watanabe I; Nara F; Serizawa N
Gene; 1995 Sep; 163(1):81-5. PubMed ID: 7557483
[TBL] [Abstract][Full Text] [Related]
3. Crystallization and preliminary X-ray diffraction analysis of cytochrome P450sca-2 from Streptomyces carbophilus involved in production of pravastatin sodium, a tissue-selective inhibitor of HMG-CoA reductase.
Ito S; Matsuoka T; Watanabe I; Kagasaki T; Serizawa N; Hata T
Acta Crystallogr D Biol Crystallogr; 1999 Jun; 55(Pt 6):1209-11. PubMed ID: 10329788
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
Matsuoka T; Miyakoshi S; Tanzawa K; Nakahara K; Hosobuchi M; Serizawa N
Eur J Biochem; 1989 Oct; 184(3):707-13. PubMed ID: 2509201
[TBL] [Abstract][Full Text] [Related]
5. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Serizawa N; Matsuoka T
Biochim Biophys Acta; 1991 Jun; 1084(1):35-40. PubMed ID: 1905157
[TBL] [Abstract][Full Text] [Related]
6. Construction of a novel expression vector in Pseudonocardia autotrophica and its application to efficient biotransformation of compactin to pravastatin, a specific HMG-CoA reductase inhibitor.
Fujii Y; Norihisa K; Fujii T; Aritoku Y; Kagawa Y; Sallam KI; Johdo O; Arisawa A; Tamura T
Biochem Biophys Res Commun; 2011 Jan; 404(1):511-6. PubMed ID: 21144838
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of an ML-236B (compactin) biosynthetic gene cluster in Penicillium citrinum.
Abe Y; Suzuki T; Ono C; Iwamoto K; Hosobuchi M; Yoshikawa H
Mol Genet Genomics; 2002 Jul; 267(5):636-46. PubMed ID: 12172803
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and molecular approaches for production of pravastatin, a potent cholesterol-lowering drug.
Serizawa N
Biotechnol Annu Rev; 1996; 2():373-89. PubMed ID: 9704102
[TBL] [Abstract][Full Text] [Related]
9. [Research and development of pravastatin].
Kishida Y; Naito A; Iwado S; Terahara A; Tsujita Y
Yakugaku Zasshi; 1991 Sep; 111(9):469-87. PubMed ID: 1762049
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of mlcR, a regulatory gene for ML-236B (compactin) biosynthesis in Penicillium citrinum.
Abe Y; Ono C; Hosobuchi M; Yoshikawa H
Mol Genet Genomics; 2002 Nov; 268(3):352-61. PubMed ID: 12436257
[TBL] [Abstract][Full Text] [Related]
12. Heterologous expression, purification, and characterization of cytochrome P450sca-2 and mutants with improved solubility in Escherichia coli.
Li P; Guan H; Li J; Lin Z
Protein Expr Purif; 2009 Jun; 65(2):196-203. PubMed ID: 19100328
[TBL] [Abstract][Full Text] [Related]
13. Application of computer to monitoring and control of fermentation process: Microbial conversion of ML-236B Na to pravastatin.
Hosobuchi M; Kurosawa K; Yoshikawa H
Biotechnol Bioeng; 1993 Sep; 42(7):815-20. PubMed ID: 18613128
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid regulation of a phenobarbital-inducible cytochrome P-450 gene: the presence of a functional glucocorticoid response element in the 5'-flanking region of the CYP2B2 gene.
Jaiswal AK; Haaparanta T; Luc PV; Schembri J; Adesnik M
Nucleic Acids Res; 1990 Jul; 18(14):4237-42. PubMed ID: 2377462
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the Bacillus subtilis bscR-CYP102A3 operon by the BscR repressor and differential induction of cytochrome CYP102A3 expression by oleic acid and palmitate.
Lee TR; Hsu HP; Shaw GC
J Biochem; 2001 Oct; 130(4):569-74. PubMed ID: 11574077
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of Penicillium citrinum VeA and LaeA as global regulators for ML-236B production.
Baba S; Kinoshita H; Nihira T
Curr Genet; 2012 Feb; 58(1):1-11. PubMed ID: 22198576
[TBL] [Abstract][Full Text] [Related]
17. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
[TBL] [Abstract][Full Text] [Related]
18. Semi-rational engineering of cytochrome P450sca-2 in a hybrid system for enhanced catalytic activity: insights into the important role of electron transfer.
Ba L; Li P; Zhang H; Duan Y; Lin Z
Biotechnol Bioeng; 2013 Nov; 110(11):2815-25. PubMed ID: 23737252
[TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. 1976.
Endo A; Kuroda M; Tanzawa K
Atheroscler Suppl; 2004 Oct; 5(3):39-42. PubMed ID: 15531273
[No Abstract] [Full Text] [Related]
20. Effect of increased dosage of the ML-236B (compactin) biosynthetic gene cluster on ML-236B production in Penicillium citrinum.
Abe Y; Suzuki T; Mizuno T; Ono C; Iwamoto K; Hosobuchi M; Yoshikawa H
Mol Genet Genomics; 2002 Sep; 268(1):130-7. PubMed ID: 12242508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]